Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Heather L Cohen. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Heather L Cohen zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:CNMD / CONMED Corporation | EVP & Chief HR & Legal Officer | 35 992 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Heather L Cohen. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera CNMD / CONMED Corporation – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w CNMD / CONMED Corporation. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera CNMD / CONMED Corporation — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w CNMD / CONMED Corporation. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Heather L Cohen ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 227 | 35 992 | 0,63 | 76,08 | 17 270 | 2 738 271 | |
| 2024-03-11 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -23 847 | 35 765 | -40,00 | 85,22 | -2 032 361 | 3 048 072 | |
| 2024-03-11 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 25 000 | 59 612 | 72,23 | 78,76 | 1 969 000 | 4 695 041 | |
| 2024-03-11 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -22 258 | 34 612 | -39,14 | 85,42 | -1 901 390 | 2 956 730 | |
| 2024-03-11 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 27 500 | 56 870 | 93,63 | 59,96 | 1 648 900 | 3 409 925 | |
| 2024-02-05 |
|
5 | CNMD |
CONMED Corp
401 (K) Plan |
J - Other | 38 | 5 009 | 0,76 | 109,51 | 4 157 | 548 550 | |
| 2023-07-05 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 16 | 29 370 | 0,05 | 129,10 | 2 066 | 3 791 667 | |
| 2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -2 643 | 29 354 | -8,26 | ||||
| 2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 31 997 | 18,52 | 32,93 | 164 650 | 1 053 661 | |
| 2023-04-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 219 | 26 997 | 0,82 | 98,67 | 21 609 | 2 663 794 | |
| 2023-02-06 |
|
5 | CNMD |
CONMED Corp
401 (K) Plan |
J - Other | 35 | 4 971 | 0,72 | 88,64 | 3 143 | 440 644 | |
| 2022-08-12 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -2 847 | 26 778 | -9,61 | 100,85 | -287 120 | 2 700 561 | |
| 2022-08-12 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 29 625 | 20,30 | 32,93 | 164 650 | 975 551 | |
| 2022-07-07 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 1 | 24 625 | 0,00 | 90,97 | 91 | 2 240 136 | |
| 2022-04-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 168 | 24 624 | 0,69 | 141,12 | 23 708 | 3 474 939 | |
| 2022-03-03 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
A - Award | 33 000 | 33 000 | |||||
| 2022-02-09 |
|
5 | CNMD |
CONMED Corp
401 (K) Plan |
J - Other | 31 | 4 936 | 0,63 | 141,76 | 4 385 | 699 686 | |
| 2021-05-06 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -150 | 24 456 | -0,61 | 144,15 | -21 622 | 3 525 332 | |
| 2021-05-06 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -450 | 24 606 | -1,80 | 143,33 | -64 497 | 3 526 704 | |
| 2021-05-06 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | -4 017 | 25 056 | -13,82 | 141,67 | -569 100 | 3 549 759 | |
| 2021-05-04 |
|
4 | CNMD |
CONMED Corp
Sars (Stock Appreciation Rights) |
M - Exercise | -10 000 | 0 | -100,00 | ||||
| 2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | -5 383 | 29 073 | -15,62 | 140,95 | -758 734 | 4 097 839 | |
| 2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 10 000 | 34 456 | 40,89 | 26,09 | 260 900 | 898 957 | |
| 2021-04-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 191 | 24 456 | 0,79 | 124,06 | 23 695 | 3 034 011 | |
| 2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 21 250 | 21 250 | |||||
| 2021-02-05 |
|
5 | CNMD |
CONMED CORP
401 (K) Plan |
J - Other | 52 | 4 905 | 1,08 | 112,00 | 5 865 | 549 335 | |
| 2021-01-20 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -5 000 | 0 | -100,00 | ||||
| 2021-01-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -2 533 | 24 265 | -9,45 | 116,98 | -296 310 | 2 838 520 | |
| 2021-01-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | X | 5 000 | 26 798 | 22,94 | 27,63 | 138 150 | 740 429 |
| 2020-12-17 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -5 000 | 5 000 | -50,00 | ||||
| 2020-12-17 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -2 530 | 21 798 | -10,40 | 109,73 | -277 617 | 2 391 895 | |
| 2020-12-17 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 5 000 | 24 328 | 25,87 | 27,63 | 138 150 | 672 183 | |
| 2020-05-19 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -4 000 | 0 | -100,00 | ||||
| 2020-05-19 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -2 062 | 19 328 | -9,64 | 72,41 | -149 309 | 1 399 540 | |
| 2020-05-19 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 000 | 21 390 | 23,00 | 19,26 | 77 040 | 411 971 | |
| 2020-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 224 | 17 390 | 1,30 | 54,41 | 12 188 | 946 190 | |
| 2020-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
| 2020-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -300 | 0 | -100,00 | ||||
| 2020-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -102 | 17 166 | -0,59 | 94,64 | -9 653 | 1 624 590 | |
| 2020-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 300 | 17 268 | 1,77 | ||||
| 2020-02-13 |
|
5 | CNMD |
CONMED CORP
401 (K) Plan |
J - Other | 48 | 4 852 | 1,00 | 111,83 | 5 398 | 542 645 | |
| 2019-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -520 | 0 | -100,00 | ||||
| 2019-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 520 | 16 968 | 3,16 | ||||
| 2019-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 300 | 16 448 | 1,86 | 79,02 | 23 706 | 1 299 721 | |
| 2019-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -300 | 300 | -50,00 | ||||
| 2019-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -775 | 0 | -100,00 | ||||
| 2019-03-05 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
| 2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -117 | 16 148 | -0,72 | 78,76 | -9 215 | 1 271 816 | |
| 2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 300 | 16 265 | 1,88 | ||||
| 2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -305 | 15 965 | -1,87 | 78,76 | -24 022 | 1 257 403 | |
| 2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 775 | 16 270 | 5,00 | ||||
| 2019-02-12 |
|
5 | CNMD |
CONMED CORP
401 (K) Plan |
J - Other | -42 | 4 804 | -0,86 | 64,20 | -2 687 | 308 426 | |
| 2018-11-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
P - Purchase | 900 | 1 700 | 112,50 | 68,60 | 61 742 | 116 624 | |
| 2018-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 86 | 15 495 | 0,56 | 69,54 | 5 980 | 1 077 522 | |
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -520 | 520 | -50,00 | ||||
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 0 | -100,00 | ||||
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -177 | 15 409 | -1,14 | 69,03 | -12 218 | 1 063 683 | |
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 520 | 15 586 | 3,45 | ||||
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -272 | 15 066 | -1,77 | 69,03 | -18 776 | 1 040 006 | |
| 2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 338 | 5,50 | ||||
| 2018-04-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 295 | 14 538 | 2,07 | 60,16 | 17 747 | 874 606 | |
| 2018-03-05 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 27 500 | 27 500 | |||||
| 2018-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -300 | 600 | -33,33 | ||||
| 2018-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -775 | 775 | -50,00 | ||||
| 2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -100 | 14 243 | -0,70 | 59,96 | -5 996 | 854 010 | |
| 2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 300 | 14 343 | 2,14 | ||||
| 2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -257 | 14 043 | -1,80 | 59,96 | -15 410 | 842 018 | |
| 2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 775 | 14 300 | 5,73 | ||||
| 2018-02-13 |
|
5 | CNMD |
CONMED CORP
401 (K) Plan |
J - Other | -21 | 4 846 | -0,43 | 50,97 | -1 070 | 247 001 | |
| 2018-02-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 0 | -100,00 | ||||
| 2018-02-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 101 | 13 525 | -7,53 | 63,35 | -69 748 | 856 809 | |
| 2018-02-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 14 626 | 15,84 | 16,46 | 32 920 | 240 744 | |
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -520 | 1 040 | -33,33 | ||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 800 | -50,00 | ||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 800 | -50,00 | ||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -193 | 12 626 | -1,51 | 51,90 | -10 017 | 655 289 | |
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 520 | 12 819 | 4,23 | ||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -296 | 12 299 | -2,35 | 51,90 | -15 362 | 638 318 | |
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -296 | 12 299 | -2,35 | 51,90 | -15 362 | 638 318 | |
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 12 595 | 6,78 | ||||
| 2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 12 595 | 6,78 | ||||
| 2017-03-17 |
|
4 | CNMD |
CONMED CORP
401 (K) Plan |
A - Award | 4 867 | 4 867 | 42,45 | 206 604 | 206 604 | ||
| 2017-03-14 |
|
4 | CNMD |
CONMED CORP
Common Stock |
P - Purchase | 440 | 11 291 | 4,05 | 40,00 | 17 598 | 451 595 | |
| 2017-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
| 2017-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -300 | 900 | -25,00 | ||||
| 2017-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -775 | 1 550 | -33,33 | ||||
| 2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -127 | 10 851 | -1,16 | 41,93 | -5 325 | 454 982 | |
| 2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 300 | 10 978 | 2,81 | ||||
| 2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -328 | 10 678 | -2,98 | 41,93 | -13 753 | 447 729 | |
| 2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 775 | 11 006 | 7,58 | ||||
| 2016-11-08 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 500 | 0 | -100,00 | ||||
| 2016-11-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -2 073 | 10 231 | -16,85 | 41,06 | -85 117 | 420 085 | |
| 2016-11-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 500 | 12 304 | 25,50 | 29,92 | 74 800 | 368 136 | |
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -296 | 74 527 | -0,40 | 41,06 | -12 154 | 3 060 079 | |
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -520 | 1 560 | -25,00 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 1 600 | -33,33 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 1 600 | -33,33 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 800 | -50,00 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -193 | 9 804 | -1,93 | 41,06 | -7 925 | 402 552 | |
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 520 | 9 997 | 5,49 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -296 | 9 477 | -3,03 | 41,06 | -12 154 | 389 126 | |
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -296 | 9 477 | -3,03 | 41,06 | -12 154 | 389 126 | |
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 773 | 8,92 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 773 | 8,92 | ||||
| 2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 773 | 8,92 | ||||
| 2016-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 23 500 | 23 500 | |||||
| 2016-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 1 200 | 1 200 | |||||
| 2016-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -775 | 2 325 | -25,00 | ||||
| 2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -328 | 7 965 | -3,96 | 39,87 | -13 077 | 317 565 | |
| 2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 775 | 8 293 | 10,31 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -520 | 2 080 | -20,00 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 2 400 | -25,00 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 2 400 | -25,00 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 1 600 | -33,33 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 800 | -50,00 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -188 | 7 518 | -2,44 | 55,70 | -10 472 | 418 753 | |
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 520 | 7 706 | 7,24 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 7 186 | -3,87 | 55,70 | -16 097 | 400 260 | |
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 7 186 | -3,87 | 55,70 | -16 097 | 400 260 | |
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 7 186 | -3,87 | 55,70 | -16 097 | 400 260 | |
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 7 186 | -3,87 | 55,70 | -16 097 | 400 260 | |
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 7 475 | 11,99 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 7 475 | 11,99 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 7 475 | 11,99 | ||||
| 2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 7 475 | 11,99 | ||||
| 2015-03-03 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 21 000 | 21 000 | |||||
| 2015-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 3 100 | 3 100 | |||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 6 500 | 6 500 | |||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 2 600 | 2 600 | |||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 3 200 | -20,00 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 3 200 | -20,00 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 2 400 | -25,00 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 1 600 | -33,33 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 800 | -50,00 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 5 142 | -5,32 | 44,90 | -12 976 | 230 876 | |
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 5 142 | -5,32 | 44,90 | -12 976 | 230 876 | |
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 5 142 | -5,32 | 44,90 | -12 976 | 230 876 | |
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 5 431 | 17,27 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 5 431 | 17,27 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 5 431 | 17,27 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 4 631 | -5,87 | 44,90 | -12 976 | 207 932 | |
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 4 920 | 19,42 | ||||
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -289 | 4 120 | -6,55 | 44,90 | -12 976 | 184 988 | |
| 2014-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 4 409 | 22,17 | ||||
| 2013-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | -1 200 | 2 587 | -31,69 | 32,59 | -39 108 | 84 310 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 4 000 | -33,33 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 4 000 | -33,33 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -500 | 0 | -100,00 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 466 | 3 787 | -27,91 | 33,20 | -48 671 | 125 728 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 5 253 | 61,48 | 19,26 | 38 520 | 101 173 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 358 | 3 253 | -29,45 | 33,20 | -45 086 | 108 000 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 4 611 | 76,60 | 16,46 | 32 920 | 75 897 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -438 | 2 611 | -14,37 | 33,20 | -14 542 | 86 685 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 500 | 3 049 | 19,62 | 26,69 | 13 345 | 81 378 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -600 | 0 | -100,00 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -218 | 2 549 | -7,88 | 32,93 | -7 179 | 83 939 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 600 | 2 767 | 27,69 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 10 000 | 10 000 | |||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 000 | 4 000 | |||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 3 200 | -20,00 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 3 200 | -20,00 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 2 400 | -25,00 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 1 600 | -33,33 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -200 | 0 | -100,00 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -290 | 2 167 | -11,80 | 32,93 | -9 550 | 71 359 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -290 | 2 167 | -11,80 | 32,93 | -9 550 | 71 359 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -290 | 2 167 | -11,80 | 32,93 | -9 550 | 71 359 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 2 457 | 48,28 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 2 457 | 48,28 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 1 437 | 125,59 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -290 | 637 | -31,28 | 32,93 | -9 550 | 20 976 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 927 | 629,92 | ||||
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -73 | 127 | -36,50 | 32,93 | -2 404 | 4 182 | |
| 2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 200 | 200 | |||||
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | -827 | 0 | -100,00 | 33,44 | -27 653 | ||
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 6 000 | -25,00 | ||||
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 6 000 | -25,00 | ||||
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | -1 165 | 827 | -58,48 | 34,62 | -40 328 | 28 627 | |
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | -2 522 | 1 992 | -55,87 | 34,46 | -86 916 | 68 650 | |
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 447 | 4 514 | -24,27 | 34,04 | -49 256 | 153 657 | |
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 5 961 | 50,49 | 19,26 | 38 520 | 114 809 | |
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 726 | 3 961 | -30,35 | 34,04 | -58 753 | 134 832 | |
| 2013-05-29 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 5 687 | 54,24 | 26,69 | 53 380 | 151 786 | |
| 2013-04-02 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | -2 436 | 0 | -100,00 | ||||
| 2013-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | X | -2 436 | 3 687 | -39,78 | 34,00 | -82 824 | 125 358 |
| 2013-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 436 | 6 123 | 66,07 | 31,40 | 76 490 | 192 262 | |
| 2013-04-02 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | -2 564 | 2 436 | -51,28 | ||||
| 2013-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | X | -2 564 | 3 687 | -41,02 | 34,00 | -87 176 | 125 358 |
| 2013-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 564 | 6 251 | 69,54 | 31,40 | 80 510 | 196 281 | |
| 2013-02-19 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 4 000 | -33,33 | ||||
| 2013-02-19 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | -3 000 | 3 687 | -44,86 | 30,43 | -91 290 | 112 195 | |
| 2013-02-19 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 408 | 6 687 | -17,39 | 30,78 | -43 338 | 205 826 | |
| 2013-02-19 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 8 095 | 32,81 | 16,46 | 32 920 | 133 244 | |
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -600 | 600 | -50,00 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -218 | 6 092 | -3,45 | 26,09 | -5 688 | 158 940 | |
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 600 | 6 310 | 10,51 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 10 000 | 10 000 | |||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 000 | 4 000 | |||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 3 200 | -20,00 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 3 200 | -20,00 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -800 | 2 400 | -25,00 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -200 | 200 | -50,00 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -290 | 5 710 | -4,83 | 26,09 | -7 566 | 148 974 | |
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -290 | 5 710 | -4,83 | 26,09 | -7 566 | 148 974 | |
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -290 | 5 710 | -4,83 | 26,09 | -7 566 | 148 974 | |
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 6 000 | 15,38 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 6 000 | 15,38 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 6 000 | 15,38 | ||||
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -73 | 4 180 | -1,72 | 26,09 | -1 905 | 109 056 | |
| 2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 200 | 4 253 | 4,93 | ||||
| 2012-05-18 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | -200 | 0 | -100,00 | ||||
| 2012-05-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -73 | 4 053 | -1,77 | 27,24 | -1 989 | 110 404 | |
| 2012-05-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 200 | 4 126 | 5,09 | ||||
| 2012-03-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | -1 136 | 3 926 | -22,44 | 29,00 | -32 944 | 113 854 | |
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -500 | 0 | -100,00 | ||||
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 8 000 | -20,00 | ||||
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | -2 000 | 8 000 | -20,00 | ||||
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -394 | 5 062 | -7,22 | 29,99 | -11 816 | 151 809 | |
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 500 | 5 456 | 10,09 | 19,93 | 9 965 | 108 738 | |
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 545 | 4 956 | -23,77 | 29,99 | -46 335 | 148 630 | |
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 6 501 | 44,43 | 19,26 | 38 520 | 125 209 | |
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | -1 425 | 4 501 | -24,05 | 29,99 | -42 736 | 134 985 | |
| 2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 5 926 | 50,94 | 16,46 | 32 920 | 97 542 |
